The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C., Rawls, John F., David, Lawrence A., Hunault, Gilles, Oberti, Frédéric, Calès, Paul, Diehl, Anna Mae·2016·Hepatology
DOI 10.1002/hep.28356

Cited by (1,000)

Items 301–400 of 1,000

  1. New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
    Keungmo Yang, Myeong Jun Song · 2023 · Nutrients
  2. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review
    Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Ali Usman · 2021 · Food Research International
  3. Publisher Correction: The gut–liver axis and the intersection with the microbiome
    Tripathi, Anupriya, Debelius, Justine, Brenner, David A., Karin, Michael, Loomba, Rohit, Schnabl, Bernd, Knight, Rob · 2018 · Nature Reviews Gastroenterology & Hepatology
  4. Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
    Svegliati-Baroni, Gianluca, Patrício, Bárbara, Lioci, Gessica, Macedo, Maria Paula, Gastaldelli, Amalia · 2020 · International Journal of Molecular Sciences
  5. Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease
    Wei Wang, Qian Li, Wenhui Chai, Chunyan Sun, Tiehua Zhang, Changhui Zhao, Yuan Yuan, Xinyu Wang, Huiqin Liu, Haiqing Ye · 2019 · Food Science & Nutrition
  6. Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota
    Basma A. Ahmed, Frank J. Ong, Nicole G. Barra, Denis P. Blondin, Elizabeth Gunn, Stephan M. Oreskovich, Jake C. Szamosi, Saad A. Syed, Emily K. Hutchings, Norman B. Konyer et al. · 2021 · Cell Reports Medicine
  7. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Elizabeth C. Verna · 2017 · The Lancet. Gastroenterology & hepatology
  8. The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
    Dishen Chen, Thanh H. Le, Haleh Shahidipour, Scott A. Read, Golo Ahlenstiel · 2019 · Cells
  9. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
    Aleksandra Hliwa, Bruno Ramos‐Molina, Dariusz Łaski, Adriana Mika, Tomasz Śledziński · 2021 · International Journal of Molecular Sciences
  10. Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile
    Masashi Murakami, Junichi Iwamoto, Akira Honda, Takeshi Tsuji, Makoto Tamamushi, Hajime Ueda, Tadakuni Monma, Naoki Konishi, Shoichiro Yara, Takeshi Thomas Hirayama et al. · 2018 · Inflammatory Bowel Diseases
  11. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
    María Juárez‐Fernández, Naroa Goikoetxea‐Usandizaga, David Porras, María Victoria García‐Mediavilla, Miren Bravo, Marina Serrano‐Maciá, Jorge Simón, Teresa C. Delgado, Sofía Lachiondo‐Ortega, Susana Martínez‐Flórez et al. · 2022 · Hepatology
  12. The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
    Xin Li, Feng Zeng, Yifan Huang, Bin Liu · 2019 · International Journal of Molecular Sciences
  13. Pharmacological effects of polydatin in the treatment of metabolic diseases: A review
    Jinli Luo, Shuo Chen, Li Wang, Xiaohua Zhao, Chunli Piao · 2022 · Phytomedicine
  14. Gut microbiome dysregulation drives bone damage in broiler tibial dyschondroplasia by disrupting glucose homeostasis
    Tingting Xu, Pan Chen, Chaodong Zhang, Aftab Shaukat, Luxi Lin, Ke Yue, Wenli Ding, Xishuai Tong, Kai‐Li Liu, Yanfeng He et al. · 2023 · npj Biofilms and Microbiomes
  15. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis
    Yizhong Wang, Xuefeng Gao, Xinyue Zhang, Yongmei Xiao, Jiandong Huang, Dongbao Yu, Xiaolu Li, Hui Hu, Ting Ge, Dan Li et al. · 2019 · mSystems
  16. Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice
    Kyoko Yamazaki, Tamotsu Kato, Yuuri Tsuboi, Eiji Miyauchi, Wataru Suda, Keisuke Sato, Mayuka Nakajima, Mai Yokoji, Miki Yamada‐Hara, Takahiro Tsuzuno et al. · 2021 · Frontiers in Immunology
  17. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis
    Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba · 2022 · Frontiers in Medicine
  18. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
    Gemma Aragonès, Sergio González-García, Carmen Aguilar, Cristóbal Richart, Teresa Auguet · 2019 · BioMed Research International
  19. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
    Esther Nistal, Luis E. Sáenz de Miera, María Dolores Ballesteros-Pomar, Sonia Sánchez‐Campos, María Victoria García‐Mediavilla, Begoña Álvarez-Cuenllas, Pedro Linares, Jose Luis Olcoz, M. Arias, Juan María García Lobo et al. · 2019 · Revista Española de Enfermedades Digestivas
  20. Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
    Minyi Qian, Qianqian Lyu, Yujie Liu, Hai Hu, Shilei Wang, Chuyue Pan, Xubin Duan, Yingsheng Gao, Lian‐Wen Qi, Weizhi Liu et al. · 2019 · Marine Drugs
  21. Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet–fed mice
    Shogo Takahashi, Yuhuan Luo, Suman Ranjit, Cen Xie, Andrew E. Libby, David J. Orlicky, Alexander S. Dvornikov, Xiaoxin X. Wang, Komuraiah Myakala, Bryce A. Jones et al. · 2020 · Journal of Biological Chemistry
  22. Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis
    Saman Khalesi, David Wayne Johnson, Katrin Campbell, Susan Lee Williams, Andrew Stuart Fenning, Sonia Saluja, Christopher G. Irwin · 2017 · European Journal of Nutrition
  23. Integrating molecular and ecological approaches to identify potential polymicrobial pathogens over a shrimp disease progression
    Wenfang Dai, Weina Yu, Lixia Xuan, Zhen Tao, Jinbo Xiong · 2018 · Applied Microbiology and Biotechnology
  24. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
    Cabrera-Rubio, Raul, Patterson, Angela M., Cotter, Paul D., Beraza, Naiara · 2019 · Scientific Reports
  25. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
    Takanori Ito, Mindie H. Nguyen · 2023 · Journal of Hepatocellular Carcinoma
  26. The Antioxidant Effect of Dietary Bioactives Arises from the Interplay between the Physiology of the Host and the Gut Microbiota: Involvement of Short-Chain Fatty Acids
    Rossana Cuciniello, Francesco Di Meo, Stefania Filosa, Stefania Crispi, Paolo Bergamo · 2023 · Antioxidants
  27. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
    Kai Markus Schneider, Antje Mohs, Konrad Kilic, Lena Susanna Candels, Carsten Elfers, Eveline Bennek, Lukas Ben Schneider, Felix Heymann, Nikolaus Gaßler, John Penders et al. · 2019 · International Journal of Molecular Sciences
  28. From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
    Benedetta Maria Motta, Mario Masarone, Pietro Torre, Marcello Persico · 2023 · Cancers
  29. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
    Maja Sofie Thiele, Ida Falk Villesen, Lili Niu, Stine Johansen, Karolina Sulek, Suguru Nishijima, Lore Van Espen, Marisa Isabell Keller, Mads Egerod Israelsen, Tommi Suvitaival et al. · 2024 · Journal of Hepatology
  30. Tangerine Peel-Derived Exosome-Like Nanovesicles Alleviate Hepatic Steatosis Induced by Type 2 Diabetes: Evidenced by Regulating Lipid Metabolism and Intestinal Microflora
    Junju Zou, Qianbo Song, Pang Chui Shaw, Yongjun Wu, Zhong Zuo, Rong Yu · 2024 · International Journal of Nanomedicine
  31. Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
    Zhangya He, Xiaomin Li, Hexiang Yang, Pei Wu, Shanshan Wang, Dan Cao, Xiaoxiao Catherine Guo, Zhangrui Xu, Jiayi Gao, Wanyu Zhang et al. · 2021 · Frontiers in Nutrition
  32. Circadian Rhythms, the Gut Microbiome, and Metabolic Disorders
    Eric H. Zhao, Christopher Tait, Carlos D. Minacapelli, Carolyn Catalano, Vinod K. Rustgi · 2022 · Gastro Hep Advances
  33. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression
    Anna Gudan, Dominika Jamioł-Milc, Viktoria Hawryłkowicz, Karolina Skonieczna‐Żydecka, Ewa Stachowska · 2022 · Nutrients
  34. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis
    Shashni, Babita, Tajika, Yuya, Ikeda, Yutaka, Nishikawa, Yuji, Nagasaki, Yukio · 2023 · Biomaterials
  35. Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study
    Lilong Zhang, Liuliu Zi, Tianrui Kuang, Kunpeng Wang, Zhendong Qiu, Zhongkai Wu, Li Liu, Rongqiang Liu, Peng Wang, Weixing Wang · 2023 · Frontiers in Endocrinology
  36. The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
    Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, Dimitrios Arapoglou, Adamantini Kyriacou · 2023 · Life
  37. Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice
    Jacob E. Friedman, Evgenia Dobrinskikh, Alba Alfonso Garcia, Alexander Fast, Rachel C. Janssen, Taylor K. Soderborg, Aimee L. Anderson, Julie A. Reisz, Angelo D’Alessandro, Daniel N. Frank et al. · 2018 · Hepatology Communications
  38. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
    Brandon J. Perumpail, Andrew A. Li, Nimy John, Sandy Sallam, Neha D. Shah, Waiyee Kwong, George T. Cholankeril, Donghee Kim, Aijaz Ahmed · 2019 · Diseases
  39. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
    Xiaoxiao Wang, Huiying Rao, Feng Liu, Lai Wei, Honggui Li, Chaodong Wu · 2021 · Cells
  40. Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut
    Kyung Hyun Kim, Dongbin Park, Baolei Jia, Ju Hye Baek, Yoonsoo Hahn, Che Ok Jeon · 2022 · mSystems
  41. Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake
    Kexin Nie, Yang Gao, Shen Chen, Zhi Wang, Hongzhan Wang, Yueheng Tang, Hao Su, Fuer Lu, Hui Dong, Ke Fang · 2023 · Phytomedicine
  42. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis
    Schröder, Torsten, Kucharczyk, David, Bär, Florian, Pagel, René, Derer, Stefanie, Jendrek, Sebastian Torben, Sünderhauf, Annika, Brethack, Ann-Kathrin, Hirose, Misa, Möller, Steffen et al. · 2016 · Molecular Metabolism
  43. A meta-analysis reveals universal gut bacterial signatures for diagnosing the incidence of shrimp disease
    Weina Yu, Jer‐Horng Wu, Jinjie Zhang, Wen Yang, Jiong Chen, Jinbo Xiong · 2018 · FEMS Microbiology Ecology
  44. Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions
    María Juárez‐Fernández, David Porras, María Victoria García‐Mediavilla, Sara Román-Sagüillo, Javier González‐Gallego, Esther Nistal, Sonia Sánchez‐Campos · 2020 · Nutrients
  45. Personalized microbiome‐based approaches to metabolic syndrome management and prevention: 使用基于微生物的个体化治疗方法来管理与预防代谢综合征
    Shapiro, Hagit, Suez, Jotham, Elinav, Eran · 2017 · Journal of Diabetes
  46. Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury
    Darrick K. Li, Snehal N. Chaudhari, Mozhdeh Sojoodi, Yoojin Lee, Arijit A. Adhikari, Lawrence R. Zukerberg, Stuti G. Shroff, Stephen Cole Barrett, Kenneth K. Tanabe, Raymond T. Chung et al. · 2022 · Science Advances
  47. Lactobacillus reuteri ZJ617 Culture Supernatant Attenuates Acute Liver Injury Induced in Mice by Lipopolysaccharide
    Yanjun Cui, Sirui Qi, Wenming Zhang, Jiangdi Mao, Renlong Tang, Chong Wang, Jianxin Liu, Xin Luo, Haifeng Wang · 2019 · Journal of Nutrition
  48. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non‐alcoholic fatty liver disease
    Nienke Koopman, Antonio Molinaro, Max Nieuwdorp, Adriaan Georgius Holleboom · 2019 · Alimentary Pharmacology & Therapeutics
  49. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
    Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani · 2021 · Nutrients
  50. Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
    Koning, Mijra, Herrema, Hilde, Nieuwdorp, Max, Meijnikman, Abraham S. · 2023 · Gut Microbes
  51. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
    So Yeong Cheon, Juhyun Song · 2022 · Cell & Bioscience
  52. Effects of Probiotic Supplementation during Pregnancy on the Future Maternal Risk of Metabolic Syndrome
    Aleksandra Obuchowska, Kamila Gorczyca, Arkadiusz Standyło, Karolina Obuchowska, Żaneta Kimber-Trojnar, Magdalena Wierzchowska-Opoka, Bożena Leszczyńska‐Gorzelak · 2022 · International Journal of Molecular Sciences
  53. Treating inflammation to combat non-alcoholic fatty liver disease
    Leke Wiering, Frank Tacke · 2022 · Journal of Endocrinology
  54. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
    Xiaoyan Li, Hua Wang · 2020 · Cell & Bioscience
  55. TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD
    Liebold, Imke, Meyer, Simon, Heine, Markus, Kuhl, Anastasia, Witt, Jennifer, Eissing, Leah, Fischer, Alexander, Koop, Anja, Kluwe, Johannes, Schulze zur Wiesch, Julian et al. · 2023 · Cells
  56. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets
    Luca Miele, Maria Adele Alberelli, Maurizio Martini, Antonio Liguori, Giuseppe Marrone, Alessandra Cocomazzi, Fabio Maria Vecchio, Raffaele Landolfi, Antonio Gasbarrini, Antonio Grieco et al. · 2020 · Translational research
  57. Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
    Chunhao Cao, Siran Yue, Aiping Lü, Chao Liang · 2024 · Pharmacological Research
  58. Reciprocal interactions between bile acids and gut microbiota in human liver diseases
    Tadashi Ikegami, Akira Honda · 2017 · Hepatology Research
  59. Constant Light Exposure Alters Gut Microbiota and Promotes the Progression of Steatohepatitis in High Fat Diet Rats
    Wei Lin, Fangzhi Yue, Xing Lin, Shanyu Wu, Ying Shi, Jinchen Li, Xingwei Xiang, Sin Man Lam, Guanghou Shui, Ryan Russell et al. · 2020 · Frontiers in Microbiology
  60. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
    Sally Naji Temraz, Farah J. Nassar, Firas Kreidieh, Deborah Mukherji, Ali I. Shamseddine, Rihab Nasr · 2021 · International Journal of Molecular Sciences
  61. Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet
    Ji‐Hee Shin, Yoonmi Lee, Eun‐Ji Song, Dokyung Lee, Seo-Yul Jang, Hye Rim Byeon, Moon-Gi Hong, Sang‐Nam Lee, Hyun‐Jin Kim, Jae‐Gu Seo et al. · 2023 · Frontiers in Microbiology
  62. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
    Yufang Ding, Karin Yanagi, Fang Yang, Evelyn S. Callaway, Clint Cheng, Martha E. Hensel, Rani Menon, Robert Christopher Alaniz, Kyongbum Lee, Arul Jayaraman · 2023 · eLife
  63. Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases
    Jumpei Fujiki, Bernd Schnabl · 2023 · JHEP Reports
  64. Diabetes as a risk factor for MASH progression
    Sofiya Gancheva, Michael Roden, Laurent Castéra · 2024 · Diabetes Research and Clinical Practice
  65. Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review
    Aref Yarahmadi, Hamed Afkhami, Ali Javadi, Mojtaba Kashfi · 2024 · Diabetology & Metabolic Syndrome
  66. NAFLD, Helicobacter species and the intestinal microbiome
    Natalia Castaño‐Rodríguez, Hazel M. Mitchell, Nadeem Omar Kaakoush · 2017 · Best Practice & Research Clinical Gastroenterology
  67. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents
    Oana Belei, Laura Olariu, Andreea Iulia Dobrescu, Tamara Marcela Marcovici, Otilia Mărginean · 2017 · Journal of Pediatric Endocrinology and Metabolism
  68. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
    Guohong-Liu, Qingxi-Zhao, Hongyun-Wei · 2019 · Annals of Hepatology
  69. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH
    Kavita S. Jadhav, Taylor S. Cohen · 2020 · Frontiers in Endocrinology
  70. Increased Relative Abundance of Ruminoccocus Is Associated With Reduced Cardiovascular Risk in an Obese Population
    Arun Prasath Lakshmanan, Sara Al Zaidan, Dhinoth Kumar Bangarusamy, Sahar Dahawi Al-Shamari, Wahiba Elhag, Annalisa Terranegra · 2022 · Frontiers in Nutrition
  71. The role of gut microbiota in liver disease development and treatment
    Lijun Wang, Yu‐Jui Yvonne Wan · 2019 · Liver Research
  72. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease
    Yinhua Ni, Liyang Ni, Fen Zhuge, Zhengwei Fu · 2020 · Molecular Nutrition & Food Research
  73. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies
    Rongrong Zhou, Xuegong Fan, Bernd Schnabl · 2019 · Translational research
  74. Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery
    María Eugenia Cornide‐Petronio, Ana I. Álvarez‐Mercado, Mónica B. Jiménez‐Castro, Carmen Peralta · 2020 · Nutrients
  75. Crosstalk between PPARs and gut microbiota in NAFLD
    Liwei Wu, Jingjing Li, Jiao Feng, Jie Ji, Qiang Yu, Yan Li, Yuanyuan Zheng, Weiqi Dai, Jianye Wu, Chuanyong Guo · 2021 · Biomedicine & Pharmacotherapy
  76. Gut Microbiome and Organ Fibrosis
    Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, Diana Santos Nascimento, Joana Ferreira‐Gomes, Manuel Pestana, Maria João Azevedo, Inês Soares Alencastre · 2022 · Nutrients
  77. Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
    Teresa Auguet, Laia Bertran, Andrea Barrientos‐Riosalido, Blanca Fabregat, Beatriz Villar, Carmen Aguilar, Fàtima Sabench · 2022 · International Journal of Environmental Research and Public Health
  78. Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
    Susana Gomes Rodrigues, Van der Merwe, Aleksander Ahm Krag, Reiner Wiest · 2024 · Seminars in Immunology
  79. Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches
    Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Alejandro Rubio-Zarapuz, Alexandra Martín-Rodríguez, José Francisco Tornero-Aguilera · 2024 · Biomedicines
  80. Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
    Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei · 2024 · Biomedicines
  81. Gut Microbiota of Nonalcoholic Fatty Liver Disease
    Reham Abdou, Lixin Zhu, Robert D. Baker, Susan S. Baker · 2016 · Digestive Diseases and Sciences
  82. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture
    Uday C. Ghoshal, Chalamalasetty Sreenivasa Baba, Ujjala Ghoshal, George Alexander, Asha Misra, Vivek A. Saraswat, Gourdas Choudhuri · 2017 · Indian Journal of Gastroenterology
  83. Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity
    Brandon D. Kayser, Marie Lhomme, Edi Prifti, Carla Da Cunha, Florian Marquet, Florian Chain, Isabelle Naas, Véronique Pelloux, Maria Carlota Dao, Anatol Kontush et al. · 2019 · The FASEB Journal
  84. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction
    Liang Xu, Naoto Nagata, Tsuguhito Ota · 2019 · International Journal of Molecular Sciences
  85. The Gut Microbiome and Ferroptosis in MAFLD
    Jie Ji, Liwei Wu, Jue Wei, Jianye Wu, Chuanyong Guo · 2022 · Journal of Clinical and Translational Hepatology
  86. Microbiota of the gastrointestinal tract: Friend or foe?
    M. A. Senchukova · 2023 · World Journal of Gastroenterology
  87. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis
    Ryutaro Kuraji, Takahiko Shiba, Tien Sy Dong, Yukihiro Numabe, Yvonne Lorraine Kapila · 2023 · World Journal of Gastroenterology
  88. Genetically Obese Human Gut Microbiota Induces Liver Steatosis in Germ-Free Mice Fed on Normal Diet
    Ruirui Wang, Hui Li, Xin Yang, Xinhe Xue, Liman Deng, Jian Shen, Menghui H. Zhang, Liping Zhao, Chenhong Zhang · 2018 · Frontiers in Microbiology
  89. Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice
    Ni Cheng, Sinan Chen, Xinyan Liu, Haoan Zhao, Wei Cao · 2019 · Nutrients
  90. Effects of High Carbohydrate Diet-Modulated Microbiota on Gut Health in Chinese Perch
    Yanpeng Zhang, Xu‐Fang Liang, Shan He, Chen Xu, Jie Wang, Jiao Li, Qiang-Sheng Zhu, Zhen Zhang, Lu Li, Muhammad Shoaib Alam · 2020 · Frontiers in Microbiology
  91. The influence of host genetics on liver microbiome composition in patients with NAFLD
    Carlos Jose Pirola, Adrián Salatino, Maria Florencia Quintanilla, Gustavo Osvaldo Castaño, Martin E. Garaycoechea, Silvia C. Sookoian · 2022 · EBioMedicine
  92. Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
    Qin Guo, Yun Li, Xin Dai, Bangmao Wang, Jie Zhang, Hailong Cao · 2023 · Nutrients
  93. Berberine prevents NAFLD and HCC by modulating metabolic disorders
    Xinyue Lin, Juanhong Zhang, Yajun Chu, Qiuying Nie, Junmin Zhang · 2024 · Pharmacology & Therapeutics
  94. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
    Ankita Dua, RASHMI REKHA KUMARI, Mona Singh, Roushan Kumar, Sunila Pradeep, Akinyemi I. Ojesina, Roshan Kumar · 2025 · Frontiers in Medicine
  95. Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
    Münevver Demir, Sonja Lang, Anna Martin, Fedja Farowski, Hilmar Wisplinghoff, Maria J. G. T. Vehreschild, Marcin Jan Krawczyk, Angela Nowag, Claus Jürgen Scholz, Anne Kretzschmar et al. · 2020 · Journal of Gastroenterology and Hepatology
  96. Lactobacillus acidophilus LA14 Alleviates Liver Injury
    Longxian Lv, Chunyan Yao, Yan Ren, Huiyong Jiang, Qiangqiang Wang, Kaicen Wang, Siqi Ren, Shandong Jiang, Jiafeng Xia, Shengjie Li et al. · 2021 · mSystems
  97. Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
    Ji Taek Hong, Min-Jung Lee, Sang Jun Yoon, Seok Pyo Shin, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim, Gi Soo Youn, Min Jea Shin, Young Lim Ham et al. · 2020 · Journal of Ginseng Research
  98. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
    Lihong He, Dun-Han Yao, Lingyun Wang, Lei Zhang, Xueli Bai · 2021 · Frontiers in Microbiology
  99. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
    Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo · 2016 · International Journal of Molecular Sciences
  100. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
    Tina Raselli, Tom Hearn, Annika Wyss, Kirstin Atrott, A. Misha Peter, Isabelle M. Frey-Wagner, Marianne Rebecca Spalinger, Ewerton Marques Maggio, Andreas W. Sailer, Johannes Schmitt et al. · 2019 · Journal of Lipid Research